Dry Eye Products Market Report 2026
Dry Eye Products Market Report 2026
Global Outlook – By Product Type (Artificial Tears, Anti-Inflammatory Eye Drops, Lubricating Ointments And Gels, Tear Conservation Products, Other Product Types), By Formulation (Preservative-Free Formulations, Preserved Formulations, Gel-Based Formulations, Ointment-Based Formulations), By Drug Category (Prescription Dry Eye Therapies, Over-The-Counter Dry Eye Products), By Disease Severity (Mild Dry Eye, Moderate Dry Eye, Severe Dry Eye), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies And E-Commerce, Ophthalmology And Specialty Clinics) – Market Size, Trends, Strategies, and Forecast to 2035
Dry Eye Products Market Overview
• Dry Eye Products market size has reached to $8.12 billion in 2025 • Expected to grow to $11.13 billion in 2030 at a compound annual growth rate (CAGR) of 6.6% • Growth Driver: The Rise In Dry Eye Conditions Driving The Growth Of The Market Due To Increased Screen Time And Tear Film Instability • Market Trend: Prescription Eye Drops To Address Evaporative Dry Eye • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.
What Is Covered Under Dry Eye Products Market?
Dry eye products refer to products that provide relief and alleviate the symptoms of dry eye syndrome, a condition in which the eyes do not produce enough tears, or the tears evaporate too quickly. These products lubricate the eyes, reduce inflammation, and increase moisture to relieve dryness, irritation, and discomfort. The main types of dry eye products are antibiotic drops, hormone drops, artificial tears, and others. Antibiotic drops are ophthalmic (eye) drops that contain antibiotics, which are medications used in dry eye disease treatment to eliminate infection and reduce inflammation, thereby alleviating dry eye symptoms. It also includes prescription drugs and over-the-counter drugs sold through different distribution channels such as hospital pharmacies, retail pharmacies, specialty clinics, e-commerce, and others.
What Is The Dry Eye Products Market Size and Share 2026?
The dry eye products market size has grown strongly in recent years. It will grow from $8.12 billion in 2025 to $8.62 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to increasing screen time exposure, rising aging population, growing awareness of dry eye syndrome, expanded availability of OTC eye care products, higher diagnosis rates of ocular surface disorders.What Is The Dry Eye Products Market Growth Forecast?
The dry eye products market size is expected to see strong growth in the next few years. It will grow to $11.13 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing demand for personalized eye care solutions, rising adoption of anti-inflammatory dry eye treatments, expansion of e-commerce pharmaceutical sales, growing focus on chronic eye condition management, increasing product innovation in ocular therapeutics. Major trends in the forecast period include growing demand for preservative-free artificial tears, increasing adoption of gel-based lubricants, rising focus on long-lasting dry eye formulations, expansion of combination therapy products, enhanced emphasis on symptom-specific treatments.Global Dry Eye Products Market Segmentation
1) By Product Type: Artificial Tears, Anti-Inflammatory Eye Drops, Lubricating Ointments And Gels, Tear Conservation Products, Other Product Types 2) By Formulation: Preservative-Free Formulations, Preserved Formulations, Gel-Based Formulations, Ointment-Based Formulations 3) By Drug Category: Prescription Dry Eye Therapies, Over-The-Counter Dry Eye Products 4) By Disease Severity: Mild Dry Eye, Moderate Dry Eye, Severe Dry Eye 5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies And E-Commerce, Ophthalmology And Specialty Clinics Subsegments: 1) By Artificial Tears: Preservative-Free Artificial Tears, Preserved Artificial Tears, Lipid-Based Artificial Tears, Electrolyte-Balanced Artificial Tears 2) By Anti-Inflammatory Eye Drops: Cyclosporine-Based Eye Drops, Lifitegrast-Based Eye Drops, Corticosteroid Eye Drops (Short-Term Use) 3) By Lubricating Ointments And Gels: Night-Time Lubricating Ointments, Gel-Based Lubricants, Petrolatum-Based Ointments 4) By Tear Conservation Products: Punctal Plugs, Tear-Retaining Inserts, Moisture Chamber Eye Shields 5) By Other Product Types: Rewetting Drops For Contact Lens Users, Dry Eye Relief Sprays, Lid-Margin Cleansing SolutionsWhat Is The Driver Of The Dry Eye Products Market?
The rising prevalence of dry eye conditions is expected to propel the growth of the dry eye products market going forward. Dry eye condition refers to a medical disorder in which the eyes do not produce enough tears or the tears evaporate too quickly, leading to discomfort, irritation, and potential damage to the eye’s surface. The rising prevalence of dry eye conditions is primarily due to increased screen time, which reduces blinking frequency and leads to faster tear evaporation, causing eye dryness and irritation. Dry eye products support dry eye conditions by lubricating the eyes, reducing inflammation, and restoring tear film stability to relieve discomfort and improve overall ocular health. For instance, in September 2024, according to PubMed Central, a US government research repository, a 2024 systematic review estimated the global prevalence of dry eye disease at 11.59%, while pooled estimates for the United States were about 8.1%, illustrating the measurable and growing burden across regions. Therefore, the rising prevalence of dry eye conditions is driving the growth of the dry eye products industry.Key Players In The Global Dry Eye Products Market
Major companies operating in the dry eye products market are Alcon Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Bausch Health Companies Inc., Santen Pharmaceutical Co. Ltd., Rohto Pharmaceutical Co. Ltd., Otsuka Pharmaceutical Co. Ltd., URSAPHARM Arzneimittel GmbH, AFT Pharmaceuticals Limited, Novaliq GmbH, Théa Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Cipla Ltd., Lupin Limited, Pfizer Inc., Merck & Co. Inc., Bayer AG, Prestige Consumer Healthcare Inc., Similasan AGGlobal Dry Eye Products Market Trends and Insights
Major companies in the dry eye products market are focused on developing prescription eye drops, such as perfluorohexyloctane ophthalmic solution, to address evaporative dry eye and to gain a competitive edge in the market. Perfluorohexyloctane ophthalmic solution is a specialized eye drop designed to address evaporative dry eye by reducing tear evaporation at the ocular surface. For instance, in September 2023, Bausch + Lomb, a Canada-based eye health products company, launched the Miebo, a prescription eye drops for treating dry eye disease by directly targeting tear evaporation. This is a perfluorohexyloctane ophthalmic solution designed to address signs and symptoms of dry eye, particularly in cases of evaporative dry eye. Miebo is a single-ingredient eye drop free from water, preservatives, and steroids. It spreads quickly and comfortably, reducing tear evaporation at the ocular surface.What Are Latest Mergers And Acquisitions In The Dry Eye Products Market?
In February 2025, Abdi İbrahim İlaç Sanayi ve Ticaret A.Ş., a Turkey-based pharmaceutical company, partnered with Rohto Pharmaceutical to introduce innovative eye care products in Turkey. This partnership aims to bring advanced eye care technologies, such as TearShield-based formulations, to the Turkish market, enhance patient experience, and strengthen both companies’ presence in the ophthalmic segment. ROHTO Pharmaceutical Co., Ltd. is a Japan-based company that specializes in pharmaceuticals, cosmetics, and other fast-moving consumer goods.Regional Outlook
North America was the largest region in the dry eye products market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Dry Eye Products Market?
The dry eye products market consists of sales of cyclosporine, corticosteroids, and lifitegrast. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.Dry Eye Products Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $8.62 billion |
| Revenue Forecast In 2035 | $11.13 billion |
| Growth Rate | CAGR of 6.2% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product Type, Formulation, Drug Category, Disease Severity, Distribution Channel |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Alcon Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Bausch Health Companies Inc., Santen Pharmaceutical Co. Ltd., Rohto Pharmaceutical Co. Ltd., Otsuka Pharmaceutical Co. Ltd., URSAPHARM Arzneimittel GmbH, AFT Pharmaceuticals Limited, Novaliq GmbH, Théa Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Cipla Ltd., Lupin Limited, Pfizer Inc., Merck & Co. Inc., Bayer AG, Prestige Consumer Healthcare Inc., Similasan AG |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
Frequently Asked Questions
The Dry Eye Products Market Report 2026 market was valued at $8.12 billion in 2025, increased to $8.62 billion in 2026, and is projected to reach $11.13 billion by 2030.
request a sample hereThe expected CAGR for the Dry Eye Products Market Report 2026 market during the forecast period 2025–2030 is 6.6%.
request a sample hereMajor growth driver of the market includes: The Rise In Dry Eye Conditions Driving The Growth Of The Market Due To Increased Screen Time And Tear Film Instability in the Dry Eye Products Market Report 2026 market. For further insights on this market,
request a sample hereThe dry eye products market covered in this report is segmented –
1) By Product Type: Artificial Tears, Anti-Inflammatory Eye Drops, Lubricating Ointments And Gels, Tear Conservation Products, Other Product Types
2) By Formulation: Preservative-Free Formulations, Preserved Formulations, Gel-Based Formulations, Ointment-Based Formulations
3) By Drug Category: Prescription Dry Eye Therapies, Over-The-Counter Dry Eye Products
4) By Disease Severity: Mild Dry Eye, Moderate Dry Eye, Severe Dry Eye
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies And E-Commerce, Ophthalmology And Specialty Clinics Subsegments:
1) By Artificial Tears: Preservative-Free Artificial Tears, Preserved Artificial Tears, Lipid-Based Artificial Tears, Electrolyte-Balanced Artificial Tears
2) By Anti-Inflammatory Eye Drops: Cyclosporine-Based Eye Drops, Lifitegrast-Based Eye Drops, Corticosteroid Eye Drops (Short-Term Use)
3) By Lubricating Ointments And Gels: Night-Time Lubricating Ointments, Gel-Based Lubricants, Petrolatum-Based Ointments
4) By Tear Conservation Products: Punctal Plugs, Tear-Retaining Inserts, Moisture Chamber Eye Shields
5) By Other Product Types: Rewetting Drops For Contact Lens Users, Dry Eye Relief Sprays, Lid-Margin Cleansing Solutions
request a sample here1) By Product Type: Artificial Tears, Anti-Inflammatory Eye Drops, Lubricating Ointments And Gels, Tear Conservation Products, Other Product Types
2) By Formulation: Preservative-Free Formulations, Preserved Formulations, Gel-Based Formulations, Ointment-Based Formulations
3) By Drug Category: Prescription Dry Eye Therapies, Over-The-Counter Dry Eye Products
4) By Disease Severity: Mild Dry Eye, Moderate Dry Eye, Severe Dry Eye
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies And E-Commerce, Ophthalmology And Specialty Clinics Subsegments:
1) By Artificial Tears: Preservative-Free Artificial Tears, Preserved Artificial Tears, Lipid-Based Artificial Tears, Electrolyte-Balanced Artificial Tears
2) By Anti-Inflammatory Eye Drops: Cyclosporine-Based Eye Drops, Lifitegrast-Based Eye Drops, Corticosteroid Eye Drops (Short-Term Use)
3) By Lubricating Ointments And Gels: Night-Time Lubricating Ointments, Gel-Based Lubricants, Petrolatum-Based Ointments
4) By Tear Conservation Products: Punctal Plugs, Tear-Retaining Inserts, Moisture Chamber Eye Shields
5) By Other Product Types: Rewetting Drops For Contact Lens Users, Dry Eye Relief Sprays, Lid-Margin Cleansing Solutions
Major trend in this market includes: Prescription Eye Drops To Address Evaporative Dry Eye For further insights on this market,
request a sample hereMajor companies operating in the Dry Eye Products Market Report 2026 market are Major companies operating in the dry eye products market are Alcon Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Bausch Health Companies Inc., Santen Pharmaceutical Co. Ltd., Rohto Pharmaceutical Co. Ltd., Otsuka Pharmaceutical Co. Ltd., URSAPHARM Arzneimittel GmbH, AFT Pharmaceuticals Limited, Novaliq GmbH, Théa Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Cipla Ltd., Lupin Limited, Pfizer Inc., Merck & Co. Inc., Bayer AG, Prestige Consumer Healthcare Inc., Similasan AG
request a sample hereNorth America was the largest region in the dry eye products market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dry eye products market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
request a sample here